TreeWAS – Variant ID: rs4149458

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
D10-D36 Benign neoplasms	0.534	0.466
Chapter II Neoplasms	0.532	0.468
Chapter XIV Diseases of the genitourinary system	0.532	0.468
N80-N98 Noninflammatory disorders of female genital tract	0.529	0.471
# Top node	0.522	0.478
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.512	0.488
D25 Leiomyoma of uterus	0.495	0.505
C15-C26 Malignant neoplasms of digestive organs	0.482	0.518
N95 Menopausal and other perimenopausal disorders	0.478	0.522
N60-N64 Disorders of breast	0.472	0.528
Chapter XV Pregnancy, childbirth and the puerperium	0.471	0.529
D12.8 Rectum	0.469	0.531
D25.9 Leiomyoma of uterus, unspecified	0.468	0.532
D23 Other benign neoplasms of skin	0.457	0.543
N81 Female genital prolapse	0.447	0.553
Chapter XXI Factors influencing health status and contact with health services	0.447	0.553
D12.5 Sigmoid colon	0.444	0.556
N88 Other noninflammatory disorders of cervix uteri	0.443	0.557
N84 Polyp of female genital tract	0.442	0.558
Chapter V Mental and behavioural disorders	0.439	0.561
C20 Malignant neoplasm of rectum	0.437	0.563
N95.0 Postmenopausal bleeding	0.437	0.563
C51-C58 Malignant neoplasms of female genital organs	0.431	0.569
Chapter I Certain infectious and parasitic diseases	0.430	0.570
N70-N77 Inflammatory diseases of female pelvic organs	0.427	0.573
D27 Benign neoplasm of ovary	0.426	0.574
N10-N16 Renal tubulo-interstitial diseases	0.418	0.582
Z00-Z13 Persons encountering health services for examination and investigation	0.418	0.582
N17-N19 Renal failure	0.417	0.583
N30-N39 Other diseases of urinary system	0.415	0.585
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.413	0.587
N92 Excessive, frequent and irregular menstruation	0.413	0.587
D12.0 Caecum	0.412	0.588
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.409	0.591
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.406	0.594
N80 Endometriosis	0.403	0.597
N85 Other noninflammatory disorders of uterus, except cervix	0.401	0.599
N84.0 Polyp of corpus uteri	0.400	0.600
C50-C50 Malignant neoplasm of breast	0.399	0.601
Z08 Follow-up examination after treatment for malignant neoplasm	0.397	0.603
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.391	0.609
N89 Other noninflammatory disorders of vagina	0.391	0.609
D12.6 Colon, unspecified	0.391	0.609
Chapter VI Diseases of the nervous system	0.390	0.610
N93 Other abnormal uterine and vaginal bleeding	0.389	0.611
D18 Haemangioma and lymphangioma, any site	0.388	0.612
N20-N23 Urolithiasis	0.388	0.612
N63 Unspecified lump in breast	0.386	0.614
D22 Melanocytic naevi	0.385	0.615
O94-O99 Other obstetric conditions, not elsewhere classified	0.384	0.616
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.384	0.616
D36 Benign neoplasm of other and unspecified sites	0.383	0.617
D35 Benign neoplasm of other and unspecified endocrine glands	0.383	0.617
D33 Benign neoplasm of brain and other parts of central nervous system	0.383	0.617
D32 Benign neoplasm of meninges	0.383	0.617
D31 Benign neoplasm of eye and adnexa	0.383	0.617
D30 Benign neoplasm of urinary organs	0.383	0.617
D29 Benign neoplasm of male genital organs	0.383	0.617
D28 Benign neoplasm of other and unspecified female genital organs	0.383	0.617
D26 Other benign neoplasms of uterus	0.383	0.617
D21 Other benign neoplasms of connective and other soft tissue	0.383	0.617
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.383	0.617
D19 Benign neoplasm of mesothelial tissue	0.383	0.617
D16 Benign neoplasm of bone and articular cartilage	0.383	0.617
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.383	0.617
D14 Benign neoplasm of middle ear and respiratory system	0.383	0.617
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.383	0.617
D11 Benign neoplasm of major salivary glands	0.383	0.617
D10 Benign neoplasm of mouth and pharynx	0.383	0.617
D34 Benign neoplasm of thyroid gland	0.383	0.617
D24 Benign neoplasm of breast	0.383	0.617
N62 Hypertrophy of breast	0.383	0.617
D17 Benign lipomatous neoplasm	0.382	0.618
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.382	0.618
D37-D48 Neoplasms of uncertain or unknown behaviour	0.382	0.618
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.382	0.618
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.382	0.618
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.382	0.618
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.382	0.618
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.382	0.618
C40-C41 Malignant neoplasms of bone and articular cartilage	0.382	0.618
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.382	0.618
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.382	0.618
N88.8 Other specified noninflammatory disorders of cervix uteri	0.381	0.618
N99-N99 Other disorders of the genitourinary system	0.381	0.619
N25-N29 Other disorders of kidney and ureter	0.381	0.619
N00-N08 Glomerular diseases	0.381	0.619
D00-D09 In situ neoplasms	0.380	0.620
N98 Complications associated with artificial fertilisation	0.379	0.620
N97 Female infertility	0.379	0.620
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.379	0.620
N91 Absent, scanty and rare menstruation	0.379	0.620
N90 Other noninflammatory disorders of vulva and perineum	0.379	0.620
N87 Dysplasia of cervix uteri	0.379	0.620
N82 Fistulae involving female genital tract	0.379	0.620
N96 Habitual aborter	0.379	0.620
N86 Erosion and ectropion of cervix uteri	0.379	0.620
D23.1 Skin of eyelid, including canthus	0.379	0.621
Chapter XXII Codes for special purposes	0.374	0.625
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.374	0.625
Chapter XVI Certain conditions originating in the perinatal period	0.374	0.625
O80-O84 Delivery	0.374	0.626
C18 Malignant neoplasm of colon	0.373	0.627
N60 Benign mammary dysplasia	0.371	0.629
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.369	0.631
D12.9 Anus and anal canal	0.367	0.633
D12.7 Rectosigmoid junction	0.367	0.633
D12.4 Descending colon	0.367	0.633
D12.1 Appendix	0.367	0.633
D23.5 Skin of trunk	0.365	0.635
M20-M25 Other joint disorders	0.363	0.637
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.361	0.639
Chapter VIII Diseases of the ear and mastoid process	0.360	0.640
C60-C63 Malignant neoplasms of male genital organs	0.359	0.641
C64-C68 Malignant neoplasms of urinary tract	0.357	0.643
N81.1 Cystocele	0.356	0.643
B95-B98 Bacterial, viral and other infectious agents	0.356	0.644
D25.2 Subserosal leiomyoma of uterus	0.355	0.645
D25.1 Intramural leiomyoma of uterus	0.355	0.645
D25.0 Submucous leiomyoma of uterus	0.355	0.645
O60-O75 Complications of labour and delivery	0.355	0.645
N95.2 Postmenopausal atrophic vaginitis	0.354	0.646
N81.2 Incomplete uterovaginal prolapse	0.350	0.650
Z13 Special screening examination for other diseases and disorders	0.349	0.651
Chapter VII Diseases of the eye and adnexa	0.347	0.653
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.346	0.654
C26 Malignant neoplasm of other and ill-defined digestive organs	0.346	0.654
C25 Malignant neoplasm of pancreas	0.346	0.654
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.346	0.654
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.346	0.654
C21 Malignant neoplasm of anus and anal canal	0.346	0.654
C17 Malignant neoplasm of small intestine	0.346	0.654
C16 Malignant neoplasm of stomach	0.346	0.654
C15 Malignant neoplasm of oesophagus	0.346	0.654
C23 Malignant neoplasm of gallbladder	0.346	0.654
C19 Malignant neoplasm of rectosigmoid junction	0.346	0.654
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.346	0.654
N95.9 Menopausal and perimenopausal disorder, unspecified	0.342	0.657
N95.8 Other specified menopausal and perimenopausal disorders	0.342	0.657
N95.3 States associated with artificial menopause	0.342	0.657
N95.1 Menopausal and female climacteric states	0.342	0.657
N32 Other disorders of bladder	0.341	0.659
D12.3 Transverse colon	0.340	0.660
N81.6 Rectocele	0.340	0.660
N73 Other female pelvic inflammatory diseases	0.339	0.661
C54 Malignant neoplasm of corpus uteri	0.339	0.661
N64 Other disorders of breast	0.338	0.662
N61 Inflammatory disorders of breast	0.338	0.662
O85-O92 Complications predominantly related to the puerperium	0.338	0.662
O20-O29 Other maternal disorders predominantly related to pregnancy	0.338	0.662
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.338	0.662
O00-O08 Pregnancy with abortive outcome	0.338	0.662
D12.2 Ascending colon	0.338	0.662
C56 Malignant neoplasm of ovary	0.336	0.664
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.336	0.664
N36 Other disorders of urethra	0.334	0.666
Z40-Z54 Persons encountering health services for specific procedures and health care	0.332	0.668
N92.0 Excessive and frequent menstruation with regular cycle	0.331	0.669
N17 Acute renal failure	0.329	0.671
D23.9 Skin, unspecified	0.328	0.672
D23.7 Skin of lower limb, including hip	0.328	0.672
D23.6 Skin of upper limb, including shoulder	0.328	0.672
D23.4 Skin of scalp and neck	0.328	0.672
D23.3 Skin of other and unspecified parts of face	0.328	0.672
D23.2 Skin of ear and external auricular canal	0.328	0.672
D23.0 Skin of lip	0.328	0.672
F40-F48 Neurotic, stress-related and somatoform disorders	0.327	0.672
Chapter XII Diseases of the skin and subcutaneous tissue	0.327	0.673
C43-C44 Melanoma and other malignant neoplasms of skin	0.327	0.673
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.327	0.673
A00-A09 Intestinal infectious diseases	0.326	0.674
Chapter IV Endocrine, nutritional and metabolic diseases	0.325	0.674
N72 Inflammatory disease of cervix uteri	0.324	0.676
B35-B49 Mycoses	0.323	0.677
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.323	0.677
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.322	0.678
N19 Unspecified renal failure	0.321	0.679
N81.9 Female genital prolapse, unspecified	0.321	0.679
N81.8 Other female genital prolapse	0.321	0.679
N81.5 Vaginal enterocele	0.321	0.679
N81.4 Uterovaginal prolapse, unspecified	0.321	0.679
N81.3 Complete uterovaginal prolapse	0.321	0.679
N81.0 Female urethrocele	0.321	0.679
N23 Unspecified renal colic	0.320	0.680
S60-S69 Injuries to the wrist and hand	0.319	0.681
F30-F39 Mood [affective] disorders	0.319	0.681
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.319	0.681
N85.2 Hypertrophy of uterus	0.318	0.681
F10 Mental and behavioural disorders due to use of alcohol	0.318	0.682
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.318	0.682
N88.4 Hypertrophic elongation of cervix uteri	0.318	0.682
N88.3 Incompetence of cervix uteri	0.318	0.682
N88.2 Stricture and stenosis of cervix uteri	0.318	0.682
N88.1 Old laceration of cervix uteri	0.318	0.682
N88.0 Leukoplakia of cervix uteri	0.318	0.682
N13 Obstructive and reflux uropathy	0.317	0.682
N84.9 Polyp of female genital tract, unspecified	0.317	0.683
N84.8 Polyp of other parts of female genital tract	0.317	0.683
N84.3 Polyp of vulva	0.317	0.683
N84.2 Polyp of vagina	0.317	0.683
F99-F99 Unspecified mental disorder	0.315	0.685
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.315	0.685
F80-F89 Disorders of psychological development	0.315	0.685
F70-F79 Mental retardation	0.315	0.685
F60-F69 Disorders of adult personality and behaviour	0.315	0.685
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.315	0.685
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.315	0.685
F00-F09 Organic, including symptomatic, mental disorders	0.315	0.685
G50-G59 Nerve, nerve root and plexus disorders	0.315	0.685
O47 False labour	0.314	0.686
Z04 Examination and observation for other reasons	0.314	0.686
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis	0.314	0.686
N80.9 Endometriosis, unspecified	0.313	0.687
N40-N51 Diseases of male genital organs	0.311	0.688
M25 Other joint disorders, not elsewhere classified	0.311	0.689
Z70-Z76 Persons encountering health services in other circumstances	0.311	0.689
C57 Malignant neoplasm of other and unspecified female genital organs	0.309	0.691
C53 Malignant neoplasm of cervix uteri	0.309	0.691
C51 Malignant neoplasm of vulva	0.309	0.691
C58 Malignant neoplasm of placenta	0.309	0.691
C55 Malignant neoplasm of uterus, part unspecified	0.309	0.691
C52 Malignant neoplasm of vagina	0.309	0.691
M65-M68 Disorders of synovium and tendon	0.309	0.691
M40-M43 Deforming dorsopathies	0.309	0.691
B99-B99 Other infectious diseases	0.308	0.692
B90-B94 Sequelae of infectious and parasitic diseases	0.308	0.692
B85-B89 Pediculosis, acariasis and other infestations	0.308	0.692
B65-B83 Helminthiases	0.308	0.692
B50-B64 Protozoal diseases	0.308	0.692
B20-B24 Human immunodeficiency virus [HIV] disease	0.308	0.692
B15-B19 Viral hepatitis	0.308	0.692
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.308	0.692
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.308	0.692
A80-A89 Viral infections of the central nervous system	0.308	0.692
A75-A79 Rickettsioses	0.308	0.692
A70-A74 Other diseases caused by chlamydiae	0.308	0.692
A65-A69 Other spirochaetal diseases	0.308	0.692
A50-A64 Infections with a predominantly sexual mode of transmission	0.308	0.692
A20-A28 Certain zoonotic bacterial diseases	0.308	0.692
A15-A19 Tuberculosis	0.308	0.692
N32.8 Other specified disorders of bladder	0.308	0.692
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.306	0.693
N76 Other inflammation of vagina and vulva	0.306	0.693
N75 Diseases of Bartholin's gland	0.306	0.693
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.306	0.693
N71 Inflammatory disease of uterus, except cervix	0.306	0.693
N70 Salpingitis and oophoritis	0.306	0.693
N85.0 Endometrial glandular hyperplasia	0.306	0.694
Z03 Medical observation and evaluation for suspected diseases and conditions	0.306	0.694
N92.1 Excessive and frequent menstruation with irregular cycle	0.305	0.694
S80-S89 Injuries to the knee and lower leg	0.305	0.695
O80 Single spontaneous delivery	0.304	0.696
C50 Malignant neoplasm of breast	0.303	0.697
A30-A49 Other bacterial diseases	0.303	0.697
C79 Secondary malignant neoplasm of other sites	0.302	0.698
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.302	0.698
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.302	0.698
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.300	0.700
N15 Other renal tubulo-interstitial diseases	0.300	0.700
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.300	0.700
N11 Chronic tubulo-interstitial nephritis	0.300	0.700
N10 Acute tubulo-interstitial nephritis	0.300	0.700
Z11 Special screening examination for infectious and parasitic diseases	0.300	0.700
Z10 Routine general health check-up of defined subpopulation	0.300	0.700
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.300	0.700
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.299	0.701
Z30 Contraceptive management	0.299	0.701
M45-M49 Spondylopathies	0.298	0.701
N60.1 Diffuse cystic mastopathy	0.298	0.702
N37 Urethral disorders in diseases classified elsewhere	0.298	0.702
N34 Urethritis and urethral syndrome	0.298	0.702
N33 Bladder disorders in diseases classified elsewhere	0.298	0.702
N30 Cystitis	0.298	0.702
N35 Urethral stricture	0.297	0.703
C80 Malignant neoplasm without specification of site	0.296	0.703
C76 Malignant neoplasm of other and ill-defined sites	0.296	0.703
N92.5 Other specified irregular menstruation	0.296	0.704
N92.4 Excessive bleeding in the premenopausal period	0.296	0.704
N92.3 Ovulation bleeding	0.296	0.704
N92.2 Excessive menstruation at puberty	0.296	0.704
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.296	0.704
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.295	0.704
C18.0 Caecum	0.295	0.705
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.293	0.707
M91-M94 Chondropathies	0.293	0.707
M86-M90 Other osteopathies	0.293	0.707
M60-M63 Disorders of muscles	0.293	0.707
M00-M03 Infectious arthropathies	0.293	0.707
N89.8 Other specified noninflammatory disorders of vagina	0.292	0.708
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.291	0.708
N83.7 Haematoma of broad ligament	0.291	0.708
N83.6 Haematosalpinx	0.291	0.708
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.291	0.708
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.291	0.708
N83.3 Acquired atrophy of ovary and Fallopian tube	0.291	0.708
N83.1 Corpus luteum cyst	0.291	0.708
N83.0 Follicular cyst of ovary	0.291	0.708
C77.5 Intrapelvic lymph nodes	0.291	0.709
B25-B34 Other viral diseases	0.291	0.709
D22.3 Melanocytic naevi of other and unspecified parts of face	0.289	0.710
N80.8 Other endometriosis	0.289	0.711
N80.6 Endometriosis in cutaneous scar	0.289	0.711
N80.5 Endometriosis of intestine	0.289	0.711
N80.4 Endometriosis of rectovaginal septum and vagina	0.289	0.711
N80.3 Endometriosis of pelvic peritoneum	0.289	0.711
N80.2 Endometriosis of Fallopian tube	0.289	0.711
N80.1 Endometriosis of ovary	0.289	0.711
N80.0 Endometriosis of uterus	0.289	0.711
G90-G99 Other disorders of the nervous system	0.288	0.712
S50-S59 Injuries to the elbow and forearm	0.288	0.712
N85.9 Noninflammatory disorder of uterus, unspecified	0.287	0.713
N85.7 Haematometra	0.287	0.713
N85.6 Intra-uterine synechiae	0.287	0.713
N85.5 Inversion of uterus	0.287	0.713
N85.4 Malposition of uterus	0.287	0.713
N85.3 Subinvolution of uterus	0.287	0.713
N85.1 Endometrial adenomatous hyperplasia	0.287	0.713
Chapter XX External causes of morbidity and mortality	0.285	0.714
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.285	0.715
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.285	0.715
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.285	0.715
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.285	0.715
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.285	0.715
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.285	0.715
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.284	0.716
N92.6 Irregular menstruation, unspecified	0.284	0.716
G80-G83 Cerebral palsy and other paralytic syndromes	0.283	0.716
D18.0 Haemangioma, any site	0.283	0.716
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.283	0.717
M80-M85 Disorders of bone density and structure	0.283	0.717
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.283	0.717
M70-M79 Other soft tissue disorders	0.282	0.718
O48 Prolonged pregnancy	0.282	0.718
M20 Acquired deformities of fingers and toes	0.282	0.718
N18 Chronic renal failure	0.281	0.719
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.281	0.719
T79-T79 Certain early complications of trauma	0.281	0.719
T66-T78 Other and unspecified effects of external causes	0.281	0.719
T33-T35 Frostbite	0.281	0.719
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.281	0.719
T26-T28 Burns and corrosions confined to eye and internal organs	0.281	0.719
T20-T25 Burns and corrosions of external body surface, specified by site	0.281	0.719
T15-T19 Effects of foreign body entering through natural orifice	0.281	0.719
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.281	0.719
T00-T07 Injuries involving multiple body regions	0.281	0.719
S90-S99 Injuries to the ankle and foot	0.281	0.719
S40-S49 Injuries to the shoulder and upper arm	0.281	0.719
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.281	0.719
S20-S29 Injuries to the thorax	0.281	0.719
S10-S19 Injuries to the neck	0.281	0.719
N89.9 Noninflammatory disorder of vagina, unspecified	0.280	0.720
N89.7 Haematocolpos	0.280	0.720
N89.6 Tight hymenal ring	0.280	0.720
N89.5 Stricture and atresia of vagina	0.280	0.720
N89.4 Leukoplakia of vagina	0.280	0.720
N89.3 Dysplasia of vagina, unspecified	0.280	0.720
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.280	0.720
N89.1 Moderate vaginal dysplasia	0.280	0.720
N89.0 Mild vaginal dysplasia	0.280	0.720
G70-G73 Diseases of myoneural junction and muscle	0.280	0.720
G30-G32 Other degenerative diseases of the nervous system	0.280	0.720
G20-G26 Extrapyramidal and movement disorders	0.280	0.720
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.280	0.720
G00-G09 Inflammatory diseases of the central nervous system	0.280	0.720
N83.2 Other and unspecified ovarian cysts	0.279	0.721
E65-E68 Obesity and other hyperalimentation	0.279	0.721
N93.0 Postcoital and contact bleeding	0.279	0.721
O34 Maternal care for known or suspected abnormality of pelvic organs	0.279	0.721
D18.1 Lymphangioma, any site	0.278	0.721
N22 Calculus of urinary tract in diseases classified elsewhere	0.278	0.722
N21 Calculus of lower urinary tract	0.278	0.722
M05-M14 Inflammatory polyarthropathies	0.278	0.722
T36-T50 Poisoning by drugs, medicaments and biological substances	0.278	0.722
N73.6 Female pelvic peritoneal adhesions	0.276	0.723
D22.9 Melanocytic naevi, unspecified	0.276	0.724
D22.7 Melanocytic naevi of lower limb, including hip	0.276	0.724
D22.6 Melanocytic naevi of upper limb, including shoulder	0.276	0.724
D22.4 Melanocytic naevi of scalp and neck	0.276	0.724
D22.2 Melanocytic naevi of ear and external auricular canal	0.276	0.724
D22.1 Melanocytic naevi of eyelid, including canthus	0.276	0.724
D22.0 Melanocytic naevi of lip	0.276	0.724
M50-M54 Other dorsopathies	0.276	0.724
S70-S79 Injuries to the hip and thigh	0.276	0.724
N36.8 Other specified disorders of urethra	0.276	0.724
C77.3 Axillary and upper limb lymph nodes	0.276	0.724
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.275	0.724
O97 Death from sequelae of direct obstetric causes	0.275	0.724
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.275	0.724
O95 Obstetric death of unspecified cause	0.275	0.724
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.275	0.724
O46 Antepartum haemorrhage, not elsewhere classified	0.275	0.725
O45 Premature separation of placenta [abruptio placentae]	0.275	0.725
O44 Placenta praevia	0.275	0.725
O43 Placental disorders	0.275	0.725
O42 Premature rupture of membranes	0.275	0.725
O41 Other disorders of amniotic fluid and membranes	0.275	0.725
O36 Maternal care for other known or suspected foetal problems	0.275	0.725
O35 Maternal care for known or suspected foetal abnormality and damage	0.275	0.725
O33 Maternal care for known or suspected disproportion	0.275	0.725
O32 Maternal care for known or suspected malpresentation of foetus	0.275	0.725
O31 Complications specific to multiple gestation	0.275	0.725
O30 Multiple gestation	0.275	0.725
O40 Polyhydramnios	0.275	0.725
D10.9 Pharynx, unspecified	0.275	0.725
D10.7 Hypopharynx	0.275	0.725
D10.6 Nasopharynx	0.275	0.725
D10.5 Other parts of oropharynx	0.275	0.725
D10.4 Tonsil	0.275	0.725
D10.3 Other and unspecified parts of mouth	0.275	0.725
D10.2 Floor of mouth	0.275	0.725
D10.1 Tongue	0.275	0.725
D10.0 Lip	0.275	0.725
D11.9 Major salivary gland, unspecified	0.275	0.725
D11.7 Other major salivary glands	0.275	0.725
D11.0 Parotid gland	0.275	0.725
D13.9 Ill-defined sites within the digestive system	0.275	0.725
D13.7 Endocrine pancreas	0.275	0.725
D13.6 Pancreas	0.275	0.725
D13.5 Extrahepatic bile ducts	0.275	0.725
D13.4 Liver	0.275	0.725
D13.3 Other and unspecified parts of small intestine	0.275	0.725
D13.2 Duodenum	0.275	0.725
D13.1 Stomach	0.275	0.725
D13.0 Oesophagus	0.275	0.725
D14.4 Respiratory system, unspecified	0.275	0.725
D14.3 Bronchus and lung	0.275	0.725
D14.2 Trachea	0.275	0.725
D14.1 Larynx	0.275	0.725
D14.0 Middle ear, nasal cavity and accessory sinuses	0.275	0.725
D15.9 Intrathoracic organ, unspecified	0.275	0.725
D15.7 Other specified intrathoracic organs	0.275	0.725
D15.2 Mediastinum	0.275	0.725
D15.1 Heart	0.275	0.725
D15.0 Thymus	0.275	0.725
D16.9 Bone and articular cartilage, unspecified	0.275	0.725
D16.8 Pelvic bones, sacrum and coccyx	0.275	0.725
D16.7 Ribs, sternum and clavicle	0.275	0.725
D16.6 Vertebral column	0.275	0.725
D16.5 Lower jaw bone	0.275	0.725
D16.4 Bones of skull and face	0.275	0.725
D16.3 Short bones of lower limb	0.275	0.725
D16.2 Long bones of lower limb	0.275	0.725
D16.1 Short bones of upper limb	0.275	0.725
D16.0 Scapula and long bones of upper limb	0.275	0.725
D19.9 Mesothelial tissue, unspecified	0.275	0.725
D19.7 Mesothelial tissue of other sites	0.275	0.725
D19.1 Mesothelial tissue of peritoneum	0.275	0.725
D19.0 Mesothelial tissue of pleura	0.275	0.725
D20.1 Peritoneum	0.275	0.725
D20.0 Retroperitoneum	0.275	0.725
D21.9 Connective and other soft tissue, unspecified	0.275	0.725
D21.6 Connective and other soft tissue of trunk, unspecified	0.275	0.725
D21.5 Connective and other soft tissue of pelvis	0.275	0.725
D21.4 Connective and other soft tissue of abdomen	0.275	0.725
D21.3 Connective and other soft tissue of thorax	0.275	0.725
D21.2 Connective and other soft tissue of lower limb, including hip	0.275	0.725
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.275	0.725
D21.0 Connective and other soft tissue of head, face and neck	0.275	0.725
D26.9 Uterus, unspecified	0.275	0.725
D26.7 Other parts of uterus	0.275	0.725
D26.1 Corpus uteri	0.275	0.725
D26.0 Cervix uteri	0.275	0.725
D28.9 Female genital organ, unspecified	0.275	0.725
D28.7 Other specified female genital organs	0.275	0.725
D28.2 Uterine tubes and ligaments	0.275	0.725
D28.1 Vagina	0.275	0.725
D28.0 Vulva	0.275	0.725
D29.9 Male genital organ, unspecified	0.275	0.725
D29.7 Other male genital organs	0.275	0.725
D29.4 Scrotum	0.275	0.725
D29.3 Epididymis	0.275	0.725
D29.2 Testis	0.275	0.725
D29.1 Prostate	0.275	0.725
D29.0 Penis	0.275	0.725
D30.9 Urinary organ, unspecified	0.275	0.725
D30.7 Other urinary organs	0.275	0.725
D30.4 Urethra	0.275	0.725
D30.3 Bladder	0.275	0.725
D30.2 Ureter	0.275	0.725
D30.1 Renal pelvis	0.275	0.725
D30.0 Kidney	0.275	0.725
D31.9 Eye, unspecified	0.275	0.725
D31.6 Orbit, unspecified	0.275	0.725
D31.5 Lachrymal gland and duct	0.275	0.725
D31.4 Ciliary body	0.275	0.725
D31.3 Choroid	0.275	0.725
D31.2 Retina	0.275	0.725
D31.1 Cornea	0.275	0.725
D31.0 Conjunctiva	0.275	0.725
D32.9 Meninges, unspecified	0.275	0.725
D32.1 Spinal meninges	0.275	0.725
D32.0 Cerebral meninges	0.275	0.725
D33.9 Central nervous system, unspecified	0.275	0.725
D33.7 Other specified parts of central nervous system	0.275	0.725
D33.4 Spinal cord	0.275	0.725
D33.3 Cranial nerves	0.275	0.725
D33.2 Brain, unspecified	0.275	0.725
D33.1 Brain, infratentorial	0.275	0.725
D33.0 Brain, supratentorial	0.275	0.725
D35.9 Endocrine gland, unspecified	0.275	0.725

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations